Association of prescription drug monitoring programs with benzodiazepine prescription dispensation and overdose in adolescents and young adults

References

• National Institute on Drug Abuse. Overdose death rates [Internet] [cited 2021 Oct 5]. Available from: https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates.
   Google Scholar
• Lim JK, Earlywine JJ, Bagley SM, et al. Polysubstance involvement in opioid overdose deaths in adolescents and young adults, 1999–2018. JAMA Pediatr. 2021;175(2):194–196.
   PubMed Web of Science ®Google Scholar
• Liu S, O'Donnell J, Gladden RM, et al. Trends in nonfatal and fatal overdoses involving benzodiazepines – 38 states and the District of Columbia, 2019–2020. MMWR Morb Mortal Wkly Rep. 2021;70(34):1136–1141.
   PubMed Web of Science ®Google Scholar
• Chua K-P, Brummett CM, Conti RM, et al. Association of opioid prescribing patterns with prescription opioid overdose in adolescents and young adults. JAMA Pediatr. 2020;174(2):141.
   PubMed Web of Science ®Google Scholar
• Macleod J, Steer C, Tilling K, et al. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: observational study based on the UK clinical practice research datalink and office for national statistics death records. PLOS Med. 2019;16(11):e1002965–16.
   PubMed Web of Science ®Google Scholar
• Toce MS, Michelson KA, Hudgins JD, et al. Trends in benzodiazepine prescribing for US adolescents and young adults from 2008 to 2019. JAMA Pediatr. 2021;66:697–704.
   Google Scholar
• Bushnell G, Samples H, Gerhard T, et al. Benzodiazepine and stimulant prescriptions before overdose in youth. Pediatrics. 2022;149(4):e2021055226.
   PubMed Web of Science ®Google Scholar
• Haffajee RL, Mello MM, Zang F, et al. Four states with robust prescription drug monitoring programs reduced opioid dosages. Health Aff. 2018;37(6):964–974.
   PubMed Web of Science ®Google Scholar
• Bao Y, Pan Y, Taylor A, et al. Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Aff. 2016;35(6):1045–1051.
   PubMed Web of Science ®Google Scholar
• Dowell D, Zhang K, Noonan RK, et al. Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates. Health Aff. 2016;35(10):1876–1883.
   PubMed Web of Science ®Google Scholar
• Rutkow L, Chang H-Y, Daubresse M, et al. Effect of florida’s prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Intern Med. 2015;175(10):1642–1649.
   PubMed Web of Science ®Google Scholar
• Cerdá M, Ponicki WR, Smith N, et al. Measuring relationships between proactive reporting state-level prescription drug monitoring programs and county-level fatal prescription opioid overdoses. Epidemiology. 2020;31(1):32–42.
   PubMed Web of Science ®Google Scholar
• Finley EP, Garcia A, Rosen K, et al. Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Serv Res. 2017;17(1):420.
   PubMedGoogle Scholar
• Prescription Drug Abuse Policy System. Prescription Drug Monitoring Program. State laws and regulations governing the operation and use of programs tracking prescription and dispensing of controlled substances [Internet] [cited 2017 Dec 1]. Available from: http://pdaps.org/.
   Google Scholar
• Prescription Drug Monitoring Program Training and Technical Assistance Center. PDMP Policies and Practices [Internet] [cited 2020 Jun 1]. Available from: http://www.pdmpassist.org/.
   Google Scholar
• Haffajee R, Jena A, Weiner S. Mandatory use of prescription drug monitoring programs. JAMA. 2015;313(9):891–892.
   PubMed Web of Science ®Google Scholar
• Winstanley EL, Zhang Y, Mashni R, et al. Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing. Drug Alcohol Depend. 2018;188:169–174.
   PubMed Web of Science ®Google Scholar
• Liang D, Guo H, Shi Y. Mandatory use of prescription drug monitoring program and benzodiazepine prescribing among U.S. Medicaid enrollees. Subst Abus. 2021;42(3):294–301.
   PubMed Web of Science ®Google Scholar
• Liang D, Shi Y. Prescription drug monitoring programs and drug overdose deaths involving benzodiazepines and prescription opioids. Drug Alcohol Rev. 2019;38(5):494–502.
   PubMed Web of Science ®Google Scholar
• Meinhofer A. Prescription drug monitoring programs: the role of asymmetric information on drug availability and abuse. Am J Heal Econ. 2018;4(4):504–526.
   Web of Science ®Google Scholar
• Grecu AM, Dave DM, Saffer H. Mandatory access prescription drug monitoring programs and prescription drug abuse. J Pol Anal Manage. 2019;38(1):181–209.
   PubMed Web of Science ®Google Scholar
• Toce MS, Michelson K, Hudgins J, et al. Association of state-level opioid-reduction policies with pediatric opioid poisoning. JAMA Pediatr. 2020;02115:1–8.
   Google Scholar
• Lembke A, Papac J, Humphreys K. Our other prescription drug problem. N Engl J Med. 2018;378(8):693–695.
   PubMed Web of Science ®Google Scholar
• Haffajee RL. Prescription drug monitoring programs—friend or folly in addressing the opioid-overdose crisis? N Engl J Med. 2019;381(8):699–701.
   PubMed Web of Science ®Google Scholar
• Pardo B. Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Addiction. 2017;112(10):1773–1783.
   PubMed Web of Science ®Google Scholar
• Earlywine JJ, Hadland SE, Raifman J. State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995–2017: a difference-in-differences analysis. PLOS Med. 2020;17(9):e1003272–13.
   PubMed Web of Science ®Google Scholar
• Toce MS, Michelson KA, Hudgins JD, et al. Association of prescription drug monitoring programs with opioid prescribing and overdose in adolescents and young adults. Ann Emerg Med. 2023;S0196–0644(22)01254-9.
   PubMed Web of Science ®Google Scholar
• Bushnell GA, Olfson M, Martins SS. Sex differences in US emergency department non-fatal visits for benzodiazepine poisonings in adolescents and young adults. Drug Alcohol Depend. 2021;221:108609.
   PubMed Web of Science ®Google Scholar
• Bushnell GA, Crystal S, Olfson M. Prescription benzodiazepine use in privately insured U.S. Am J Prev Med. 2019;57(6):775–785.
   PubMed Web of Science ®Google Scholar
• Sidorchuk A, Isomura K, Molero Y, et al. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study. PLOS Med. 2018;15(8):e1002635–22.
   PubMed Web of Science ®Google Scholar
• Bachhuber MA, Maughan BC, Mitra N, et al. Prescription monitoring programs and emergency department visits involving benzodiazepine misuse: early evidence from 11 United States metropolitan areas. Int J Drug Policy. 2016;28:120–123.
   PubMed Web of Science ®Google Scholar
• Bollinger K, Weimer BL, Heller D, et al. Benzodiazepines reported in NFLIS-Drug, 2015–2018. Forensic Sci Int Synerg. 2021;3:100138.
   PubMedGoogle Scholar